Trademark: 87348269
Word
A
Status Date
Wednesday, October 10, 2018
Filing Date
Friday, February 24, 2017
Abandoned Date
Wednesday, October 10, 2018
5 Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the prevention and treatment of cancer; Dermatological pharmaceutical products; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of joint disease; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Intravenous bags, syringes, and vials sold filled with injectable pharmaceutical preparations, namely, oncologic products and ancillary products, chemotherapy agents, anti-emitics, and anti-infectives; Anticholinergics; Anticholinesterases; Anti-hypotensives; Biological preparations for the treatment of cancer; Anesthetics for surgical and non-surgical use; Antibiotics; Antiemetics; Analgesics; Sedatives; Dietary supplements; Vaccines; Blood for medical purposes; all of the foregoing featuring differentiated packaging for the purpose of reducing user errors and promoting correct medication selection
Color is not claimed as a feature of the mark.
The mark consists of a stylized "A" with a swoop crossed with a curved line incepting the swoop of the "A"".
Oct 11, 2018
Abandonment Notice Mailed - After Ex Parte Appeal
Oct 10, 2018
Abandonment - After Ex Parte Appeal
Oct 10, 2018
Exparte Appeal Terminated
Oct 10, 2018
Exparte Appeal Dsmsed - Failure To File Brief
Jul 12, 2018
Notification Of Action Denying Req For Recon E-Mailed
Jul 12, 2018
Action Denying Req For Recon E-Mailed
Jul 12, 2018
Action Continuing Final - Completed
Jun 28, 2018
Teas/Email Correspondence Entered
Jun 28, 2018
Correspondence Received In Law Office
Jun 28, 2018
Assigned To Lie
Jun 13, 2018
Teas Request For Reconsideration Received
Jun 13, 2018
Ex Parte Appeal-Instituted
Jun 13, 2018
Jurisdiction Restored To Examining Attorney
Jun 13, 2018
Exparte Appeal Received At Ttab
Dec 14, 2017
Notification Of Final Refusal Emailed
Dec 14, 2017
Final Refusal E-Mailed
Dec 14, 2017
Final Refusal Written
Dec 1, 2017
Teas/Email Correspondence Entered
Nov 30, 2017
Correspondence Received In Law Office
Nov 30, 2017
Teas Response To Office Action Received
May 30, 2017
Notification Of Non-Final Action E-Mailed
May 30, 2017
Non-Final Action E-Mailed
May 30, 2017
Non-Final Action Written
May 20, 2017
Assigned To Examiner
Mar 3, 2017
Notice Of Design Search Code E-Mailed
Mar 2, 2017
New Application Office Supplied Data Entered In Tram
Feb 28, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
